A new leaked regulatory letter points to the potential to close Theranos and ban its top executives from working in the medical testing industry. The company’s fate is not certain, as it could appeal a ruling or still successfully satisfy regulators. Last week a Theranos spokesperson indicated to ValueWalk there were no issues with senior management at the company, pointing instead to issues at the Newark, CA testing facility that were being addressed. But today a March 18 letter from regulators has surfaced, revealing that in fact regulators had proposed banning Theranos Inc. founder Elizabeth Holmes and company executives including…
Regulators Could Ban Holmes, Effectively Close Theranos
Mark Melin
Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.